Brainstorm Cell Therapeutics Inc. (BCLI) surged 6.36% or 0.25 to $4.18. It is approximately 153263 shares traded, which is 192.91% compare to the average total volume 79446. The market cap of BCLI is $79.71 million. The year to date change is 7.67%. The 52 week price range is from $2.88 to $5.18. Price of BCLI have changed 13.58% during last week. It have changed 18.02% over last month, 24.37% over last 3 months, -3.44% over last 6 months and -4.84% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.39. It is -18.90% below current price. The 200-day Moving Averages for BCLI is 3.75. It is -10.29% below current price. The 52-week High is 5.18. It is 23.92% from the current price. The 52-week Low is 2.88. It is -31.10% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 24.78 on 2018-04-30. Short % to float is 8.51%. There are some statistics of BCLI. It is has market cap $79.71 million. The share outstanding is 19.07 million. The average volume is 79446. The percent of top 15 Institution holding is 9.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -62.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -44.63%.